Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies

Abstract excerpt

Diabetic cardiomyopathy (DCM) is a severe complication of diabetes developed mainly in poorly controlled patients. In DCM, several clinical manifestations as well as cellular and molecular mechanisms contribute to its phenotype. The production of reactive oxygen species (ROS), chronic low-grade inflammation, mitochondrial dysfunction, autophagic flux inhibition, altered metabolism, dysfunctional insulin...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiovascular Function and Risk Factors
• Share to Metabolism, Diabetes, and Cancer
• Share to Parkinson's Disease Mechanisms and Treatments